Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 10, 2014 - Issue 6
Submit an article Journal homepage
679
Views
9
CrossRef citations to date
0
Altmetric
Editorials

The case for measuring anti-drug antibodies in people with multiple sclerosis

Malin Lundkvist RynerDepartment of Clinical Neuroscience, Clinical Neurimmunology, Karolinska Institutet, Center for Molecular Medicine, L8:00, 171 76 Stockholm, Sweden
,
Rachel A FarrellDepartment of Neuroinflammation, UCL, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
&
Anna Fogdell-HahnDepartment of Clinical Neuroscience, Clinical Neurimmunology, Karolinska Institutet, Center for Molecular Medicine, L8:00, 171 76 Stockholm, SwedenCorrespondence[email protected]
Pages 697-699 | Published online: 30 Apr 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Fabian Richter, Oliver Seifert, Andreas Herrmann, Klaus Pfizenmaier & Roland E. Kontermann. (2019) Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc. mAbs 11:4, pages 653-665.
Read now
Fabian Richter, Kirstin A. Zettlitz, Oliver Seifert, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier & Roland E. Kontermann. (2019) Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity. mAbs 11:1, pages 166-177.
Read now
Wolf-Henning Boehncke & Nicolo Costantino Brembilla. (2018) Immunogenicity of biologic therapies: causes and consequences. Expert Review of Clinical Immunology 14:6, pages 513-523.
Read now
Uwe Klaus Zettl, Michael Hecker, Orhan Aktas, Torsten Wagner & Paulus S. Rommer. (2018) Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge. Expert Review of Clinical Immunology 14:2, pages 137-153.
Read now
Jo Lambert, Alexander Nast, Frank O. Nestle & Jörg C Prinz. (2015) Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases?. Journal of Dermatological Treatment 26:6, pages 520-527.
Read now

Articles from other publishers (4)

. 2022. Multiple Sklerose. Multiple Sklerose 468 512 .
Uwe K. Zettl, Michael Hecker & Brit Fitzner. 2018. Multiple Sklerose. Multiple Sklerose 207 210 .
Iris Grossman, Volker Knappertz, Daphna Laifenfeld, Colin Ross, Ben Zeskind, Sarah Kolitz, David Ladkani, Liat Hayardeny, Pippa Loupe, Ralph Laufer & Michael Hayden. (2017) Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research. Progress in Neurobiology 152, pages 114-130.
Crossref
Uwe K. Zettl, Michael Hecker & Brit Fitzner. 2015. Multiple Sklerose. Multiple Sklerose 211 214 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.